Evaluation of a silver-impregnated coating to inhibit colonization of orthopaedic implants by biofilm forming methicillin-resistant Staphylococcus pseudintermedius

Mohammed A. Azab; Matthew J. Allen; Joshua B. Daniels

doi:10.3415/VCOT-15-08-0134

Veterinary and Comparative Orthopaedics and Traumatology, Inhaltsverzeichnis

Vet Comp Orthop Traumatol 2016; 29(04): 347-350
DOI: 10.3415/VCOT-15-08-0134

Brief Communication

Schattauer GmbH

Evaluation of a silver-impregnated coating to inhibit colonization of orthopaedic implants by biofilm forming methicillin-resistant Staphylococcus pseudintermedius

Mohammed A. Azab

¹Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA

³Department of Surgery, Faculty of Veterinary Medicine, Damanhour University, Egypt

,

Matthew J. Allen

¹Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA

²Department of Veterinary Medicine, University of Cambridge, Cambridge, England

,

Joshua B. Daniels

¹Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA

› Institutsangaben

Abstract

Summary

Objectives: To evaluate the in vitro anti -bacterial activity of a silver-impregnated coating against a biofilm-forming strain of methicillin-resistant Staphylococcus pseud -intermedius (MRSP).

Methods: A clinical MRSP isolate sourced from a failed canine knee implant was evaluated for biofilm production and used in the present study. Using a standard test method and a clinically approved titanium substrate, the antimicrobial activity of a novel silver plasma coating was determined at two times: five minutes after inoculation of the specimens (T0) and after 24 hours of incubation (T24). Scanning electron microscopy was used to evaluate the biofilm formation on specimens.

Results: The tested clinical MRSP isolate was classified as a strong biofilm producer. The silver coating significantly reduced the MRSP growth more than four log steps compared to the non-coated specimens and showed more than 99.98% reduction in the number of colony forming units after 24 hours. Scanning electron microscopy images revealed that silver-coated surfaces did not manifest detectable biofilm, while biofilm formation was readily observed on the control specimens.

Clinical significance: The silver coating exhibited excellent activity against the multi-drug resistant biofilm-forming MRSP isolate. The next stage of this work will involve testing in an animal model of orthopaedic infection. Positive results from animal studies would support the introduction of the silver plasma coating as a new strategy for preventing implant contamination, biofilm formation, and surgical infection in dogs undergoing orthopaedic surgery.

Supplementary Material for this paper is available online at: http://dx.doi.org/10.3415/VCOT-15-08-0134

Keywords

Antibacterial - MRSP - methicillin resistant - silver - Staphylococcus pseudintermedius - preventive

Volltext

Referenzen

References
1 DiCicco M, Neethirajan S, Singh A. et al. Efficacy of clarithromycin on biofilm formation of methicillin-resistant Staphylococcus pseudintermedius. BMC Vet Res 2012; 8: 225-232.
2 Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect 2002; 4: 481-489.
3 Eugster S, Schawalder P, Gaschen F. et al. A prospective study of postoperative surgical site infections in dogs and cats. Vet Surg 2004; 33: 542-550.
4 Wettstein K, Descloux S, Rossano A. et al. Emergence of methicillin-resistant Staphylococcus pseudintermedius in Switzerland: three cases of urinary tract infections in cats. Schweiz Arch Tierheilkd 2008; 150: 339-343.
5 Wieler LH, Ewers C, Guenther S. et al. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: Nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples. Int J Med Microbiol 2011; 301: 635-641.
6 Zhao L, Chu PK, Zhang Y. et al. Antibacterial coatings on titanium implants. J Biomed Mat Res B 2009; 91: 470-480.
7 Khalilpour P, Lampe K, Wagener M. et al. Ag/SiOxCy plasma polymer coating for antimicrobial protection of fracture fixation devices. J Biomed Mater Res B 2010; 94: 196-202.
8 Furkert FH, Sörensen JH, Arnoldi J. et al. Antimicrobial efficacy of surface-coated external fixation pins. Curr Microbiol 2011; 62: 1743-1751.
9 Melaiye A, Youngs WJ. Silver and its application as an antimicrobial agent. Expert Opinion on Therapeutic Patients 2005; 15: 125-130.
10 Stepanovich S, Vukovic D, Hola V. et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007; 115: 891-899.
11 Singh A, Walker M, Rousseau J. et al. Characterization of the biofilm forming ability of Staphylococcus pseudintermedius from dogs. BMC Vet Res 2013; 9: 93-98.
12 ASTM International. Standard test method for determining the activity of incorporated antimicrobial agent(s) in polymeric or hydrophobic materials. ASTM Standard E2180-07(2012); West Conshohocken, PA (USA): ASTM International; 2012. available at http://www.astm.org/Standards/E2180.htm
13 Alt V, Bechert T, Steinrücke P. et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004; 25: 4383-4391.
14 Panácek A, Kvítek L, Prucek R. et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B 2006; 110: 16248-16253.
15 Furno F, Morley KS, Wong B. et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?. J Antimicrob Chemother 2004; 54: 1019-1024.
16 Damm C, Münstedt H, Rösch A. The antimicrobial efficacy of polyamide 6/silver-nano- and microcomposites. Mater Chem Phys 2008; 108: 61-66.
17 Meyer Ch, Keßler J, Alt V. et al. Antimicrobial effect of silver-coated external fixator pins. Osteo Trauma Care 2004; 12: 81-84.

Zusatzmaterial